ArticleScience advances2025
Nanoscale acoustic oscillator for mechanoimmunology: NAOMI.
Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrated microfluidic biosensors: shaping the future of quantitative life sciences and on-chip molecular diagnostics.Lab on a chip · 2026Review
- Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential.npj biomedical innovations · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Mechanoimmunology explores how mechanical forces orchestrate immune responses, offering insights into immune cell functions and the mechanisms underlying mechanotransduction. A critical challenge in this field is the absence of reliable platforms that apply precise, consistent mechanical stimuli to individual cells while enabling reproducible immune activation. Here, we present a nanoscale acoustic oscillator for mechanoimmunology applications: NAOMI. NAOMI features micropatterned pillars that support uniform cell monolayer formation with an integrated acoustic transducer that delivers highly controlled 3D nanoscale oscillations (±1-nanometer deviation) for up to 72 hours. Unlike conventional passive platforms relying on static stiffness or surface topography, NAOMI enables dynamic, programmable stimulation with high precision and reproducibility. Validation studies demonstrate that NAOMI notably enhances mechanical stress intensity and cell displacement, driving robust M1 polarization in macrophages. NAOMI provides a practical and versatile platform for studying mechanoimmunology, offering high precision, stability, and tunability. Its capabilities also position it well to support future research and drive innovative discoveries in the field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.